Venatorx Pharmaceuticals, Inc.
Records under this name other than the patents Venatorx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
Back to Venatorx Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,637,504 | Beta-lactamase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,783,555 | Beta-lactamase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,926,336 | Beta-lactamase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,008,346 | Beta-lactamase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,464,952 | Beta-lactamase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,590,076 | Hepatitis B capsid assembly modulators Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,566,001 | Hepatitis B Capsid Assembly Modulators Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,125,152 | Beta-Lactamase Inhibitors Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 11,414,435 | Beta-Lactamase Inhibitors Lapsed on the fee record Ended Aug 16, 2026 · Medium confidence | Lapsed on the fee record | Ended Aug 16, 2026 | Medium confidence |
| US 11,332,485 | Penicillin-binding protein inhibitors Lapsed on the fee record Ended May 17, 2026 · USPTO record | Lapsed on the fee record | Ended May 17, 2026 | USPTO record |